Fractyl Health Inc. Commo... (GUTS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Fractyl Health Common Stock Statistics
Share Statistics
Fractyl Health Common Stock has 48.10M shares outstanding. The number of shares has increased by 1.03% in one year.
Shares Outstanding | 48.10M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.36% |
Owned by Institutions (%) | n/a |
Shares Floating | 20.64M |
Failed to Deliver (FTD) Shares | 1.80K |
FTD / Avg. Volume | 0.47% |
Short Selling Information
The latest short interest is 2.21M, so 4.59% of the outstanding shares have been sold short.
Short Interest | 2.21M |
Short % of Shares Out | 4.59% |
Short % of Float | 10.7% |
Short Ratio (days to cover) | 7.34 |
Valuation Ratios
The PE ratio is -7.94 and the forward PE ratio is -0.98.
PE Ratio | -7.94 |
Forward PE | -0.98 |
PS Ratio | 5097.94 |
Forward PS | 7.9 |
PB Ratio | -1.88 |
P/FCF Ratio | -14.17 |
PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Fractyl Health Inc. Common Stock.
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.19, with a Debt / Equity ratio of -0.27.
Current Ratio | 3.19 |
Quick Ratio | 3.18 |
Debt / Equity | -0.27 |
Total Debt / Capitalization | -36.2 |
Cash Flow / Debt | -0.5 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.24% and return on capital (ROIC) is 21.3%.
Return on Equity (ROE) | 0.24% |
Return on Assets (ROA) | -1.01% |
Return on Capital (ROIC) | 21.3% |
Revenue Per Employee | 983.61 |
Profits Per Employee | -631.89K |
Employee Count | 122 |
Asset Turnover | 0 |
Inventory Turnover | 1.05 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0, so Fractyl Health Common Stock's price volatility has been lower than the market average.
Beta | 0 |
52-Week Price Change | null% |
50-Day Moving Average | 2.09 |
200-Day Moving Average | 3.71 |
Relative Strength Index (RSI) | 51.97 |
Average Volume (20 Days) | 384.64K |
Income Statement
In the last 12 months, Fractyl Health Common Stock had revenue of 120.00K and earned -77.09M in profits. Earnings per share was -1.98.
Revenue | 120.00K |
Gross Profit | 43.00K |
Operating Income | -50.84M |
Net Income | -77.09M |
EBITDA | -50.55M |
EBIT | -50.84M |
Earnings Per Share (EPS) | -1.98 |
Balance Sheet
The company has 33.21M in cash and 86.39M in debt, giving a net cash position of -53.18M.
Cash & Cash Equivalents | 33.21M |
Total Debt | 86.39M |
Net Cash | -53.18M |
Retained Earnings | -346.62M |
Total Assets | 126.92M |
Working Capital | 71.93M |
Cash Flow
In the last 12 months, operating cash flow was -42.82M and capital expenditures -359.00K, giving a free cash flow of -43.18M.
Operating Cash Flow | -42.82M |
Capital Expenditures | -359.00K |
Free Cash Flow | -43.18M |
FCF Per Share | -0.91 |
Margins
Gross margin is 35.83%, with operating and profit margins of -42.36K% and -64.24K%.
Gross Margin | 35.83% |
Operating Margin | -42.36K% |
Pretax Margin | -64.24K% |
Profit Margin | -64.24K% |
EBITDA Margin | -42.13K% |
EBIT Margin | -42.36K% |
FCF Margin | -35.98K% |
Dividends & Yields
GUTS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -97.06% |
FCF Yield | -44.12% |
Analyst Forecast
The average price target for GUTS is $18, which is 782.4% higher than the current price. The consensus rating is "Buy".
Price Target | $18 |
Price Target Difference | 782.4% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Scores
Altman Z-Score | -4.95 |
Piotroski F-Score | 4 |